Department of Vascular Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Vascular and Thyroid Surgery, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
J Vasc Surg. 2020 Sep;72(3):1109-1120.e6. doi: 10.1016/j.jvs.2020.02.052. Epub 2020 Apr 15.
The efficacy and safety of placement of a proximal covered stent graft combined with a distal bare stent are controversial because of the lack of evidence. This systematic review and meta-analysis compared the outcomes of combined proximal covered stent grafting with distal bare stenting (BS group) and proximal covered stent grafting without distal bare stenting (non-BS group).
The MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases and key references were searched up to January 26, 2019. Predefined outcomes of interest were mortality, morbidity, and postoperative assessment of aortic remodeling. We pooled risk ratios (RRs) of the outcomes of interest using fixed effects model or random effects model.
Overall, eight observational studies involving 914 patients were included. There were no significant differences in overall aorta-related mortality (RR, 0.54; confidence interval [CI], 0.24-1.24; P = .15), complete thoracic false lumen (FL) thrombosis rate (RR, 1.23; CI, 0.83-1.81; P = .30), or complete abdominal FL thrombosis rate (RR, 1.96; CI, 0.68-5.69; P = .21) between the BS group and the non-BS group. The BS group had a lower rate of partial thoracic FL thrombosis (RR, 0.40; CI, 0.25-0.65; P = .0002), a lower stent graft-induced new entry rate (RR, 0.08; CI, 0.02-0.41; P = .003), and a lower reintervention rate (RR, 0.42; CI, 0.26-0.69; P = .0005).
Combined proximal covered stent grafting with distal adjunctive bare stenting had the potential to reduce the partial thoracic FL thrombosis rate and the rates of stent graft-induced new entry and reintervention but was not associated with lower aorta-related mortality or the complete FL thrombosis rate. Further research with a stricter methodology is needed.
由于缺乏证据,近端带膜支架与远端裸支架联合放置的疗效和安全性仍存在争议。本系统评价和荟萃分析比较了近端带膜支架与远端裸支架(BS 组)联合近端带膜支架与远端无裸支架(非 BS 组)的治疗结果。
检索 MEDLINE、Embase 和 Cochrane 对照试验中心注册库,检索时间截至 2019 年 1 月 26 日。主要观察终点为死亡率、发病率和术后主动脉重塑评估。采用固定效应模型或随机效应模型对感兴趣的结局的风险比(RR)进行汇总。
共纳入 8 项观察性研究,共 914 例患者。BS 组与非 BS 组在主动脉相关死亡率(RR,0.54;95%置信区间 [CI],0.24-1.24;P=0.15)、完全性胸段假性腔血栓形成率(RR,1.23;95%CI,0.83-1.81;P=0.30)或完全性腹段假性腔血栓形成率(RR,1.96;95%CI,0.68-5.69;P=0.21)方面无显著差异。BS 组的部分胸段假性腔血栓形成率(RR,0.40;95%CI,0.25-0.65;P=0.0002)、支架内新发入口率(RR,0.08;95%CI,0.02-0.41;P=0.003)和再干预率(RR,0.42;95%CI,0.26-0.69;P=0.0005)均较低。
近端带膜支架与远端辅助裸支架联合应用可降低部分胸段假性腔血栓形成率、支架内新发入口率和再干预率,但与主动脉相关死亡率或完全性假性腔血栓形成率降低无关。需要进一步进行方法学更严格的研究。